USP GMP manufacturer Nintedanib

Min.Order / FOB Price:Get Latest Price

1 Gram	FOB Price: USD 60.0000

1 Gram

FOB Price: USD 60.0000

Min.Order :1 Gram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

nintedanib 656247-17-5 nintedanib powder

Quick Details

Appearance:Bright yellow solid
Application:Health&Medical&Beauty
PackAge:Foil Bag, According to Client's Requirement
ProductionCapacity:100|Kilogram|Day
Storage:store in cool and dry place
Transportation:FedEx DHL EMS or by Sea

Superiority:

1, High quality with competitive price:

1) Standard:BP/USP/EP/Enterprise standard

2) All Purity≥99%

3) We are manufacturer and can provide high quality products with factory price.

2, Fast and safe delivery

1) Parcel can be sent out in 24 hours after payment.Tracking number available

2) Secure and discreet shipment.Various transportation methods for your choice.

3) Customs pass rate ≥99%

4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe,

and we have stock in there for transferring.

3,We have clients throughout the world.

1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.

2) Market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility.

25) High quality,competitive price,fast delivery ,first-class service gain the trust and praise from the customers.

Details:

USP GMP manufacturer Nintedanib

Product Description

Introduction

Product Name	Nintedanib (Ofev)
Other Name	3Z)-2,3-Dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-
Molecular Formula	C31H33N5O4.C2H6O3S
Molecular Weight	649.76
CAS No.	656247-18-6
Appearance	White Powder
Key words	Treatment of idiopathic pulmonary fibrosis

Nintedanib is the first FDA-approved drug for the management of idiopathic pulmonary fibrosis (IPF), a rare but often fatal lung disease. Nintedanib is believed to exert its mechanism of action by inhibiting multiple receptor tyrosine kinases, including those that have been implicated in the pathogenesis of IPF (i.e., fibroblast growth factor receptor, platelet-derived growth factor receptor, and vascular endothelial growth factor receptor). Nintedanib also inhibits nonreceptor tyrosine kinases, although the contribution of this inhibition in the efficacy of the drug is unknown.

OEM SERVICE

CUSTOMIZE THE PRIVATE LABEL AS YOUR REQUIREMENT

1. Supply raw materials and mixed ingredients accodirng to yout formula
2. Make finished products with professional formula, design and other information
3. Different spefications or forms as your requirement, pills, capsules in bottles or packs
4. Print the customized labels and pack products according to your requirements